🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Ajay Major

University of Colorado Cancer Center

ORCID: 0000-0001-7261-1335

Also affiliated with University of Colorado Anschutz Medical Campus, University of Colorado Denver

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions”.

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Blood(2021)10.1182/blood.2021012888
N/A
0DataRank · unranked
95 citations

Daniel Reed, Ashley McCook, Jeremy Sen, Christian Barlow, Mary‐Kate Malecek +48 more

Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia(2022)10.1016/j.clml.2022.07.002
N/A
0DataRank · unranked
6 citations

Andrzej Jakubowiak, Benjamin A. Derman, Ajay Major

Multi-gene measurable residual disease assessed by digital polymerase chain reaction has clinical and biological utility in acute myeloid leukemia patients receiving venetoclax/azacitidine

Haematologica(2023)10.3324/haematol.2023.283790
N/A
0DataRank · unranked
9 citations

Mohd Minhajuddin, Brett M. Stevens, Ajay Major, Grace Bosma, Diana Abbott +9 more

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Blood Advances(2024)10.1182/bloodadvances.2024012800
N/A
0DataRank · unranked
4 citations

Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long +46 more

Beyond maximum grade: advancing the measurement and analysis of adverse events in malignant haematology trials in the modern era

The Lancet Haematology(2025)10.1016/s2352-3026(25)00035-3
N/A
0DataRank · unranked
6 citations

Amylou C. Dueck, Gita Thanarajasingam, Ajay Major

Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series

The Lancet Haematology(2025)10.1016/s2352-3026(25)00027-4
N/A
0DataRank · unranked
4 citations

Ajay Major, Vishal Bhatnagar, Amylou C. Dueck, Karin E. Smedby, Tarec Christoffer El‐Galaly +8 more